The PACIRA Trial is a multi-center, randomized, study to evaluate the safety, efficacy and pharmacokinetics of a single injection femoral nerve block with liposome bupivacaine for postoperative pain for patients undergoing a total knee replacement.
The Clinical Trails Program at Northern Westchester Hospital is actively recruiting for this trial. Enrollment will end in October.
More Articles on Clinical Trials:
MUMC Participates in Trial of Facet Joint Replacement as Spinal Stenosis Treatment
Medtronic to Recruit 323 Patients for Back Pain Treatment Clinical Trial
FDA Approves Ampion Biologic Clinical Trial
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
